Assure (NASDAQ:IONM – Get Rating) had its price target trimmed by Benchmark from $8.00 to $4.00 in a report published on Tuesday, The Fly reports.
Separately, Roth Mkm reduced their target price on Assure from $60.00 to $12.00 and set a buy rating for the company in a research report on Wednesday, April 12th.
Assure Price Performance
NASDAQ IONM opened at $1.00 on Tuesday. The company has a 50 day simple moving average of $2.63 and a 200-day simple moving average of $4.09. Assure has a 52-week low of $0.93 and a 52-week high of $113.00. The company has a debt-to-equity ratio of 7.31, a current ratio of 2.58 and a quick ratio of 2.58.
Insider Buying and Selling
Hedge Funds Weigh In On Assure
An institutional investor recently bought a new position in Assure stock. Empery Asset Management LP bought a new stake in shares of Assure Holdings Corp. (NASDAQ:IONM – Get Rating) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 56,264 shares of the company’s stock, valued at approximately $36,000. Empery Asset Management LP owned 0.43% of Assure at the end of the most recent reporting period. 6.57% of the stock is owned by institutional investors.
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.
- Get a free copy of the StockNews.com research report on Assure (IONM)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.